Using yeast to understand drugs that target topoisomerases

被引：29

作者：

Nitiss, JL ^{[1
]}

Rose, A ^{[1
]}

Sykes, KC ^{[1
]}

Harris, J ^{[1
]}

Zhou, JF ^{[1
]}

机构：

[1] UNIV SO CALIF, SCH MED, DEPT MICROBIOL, LOS ANGELES, CA 90033 USA

来源：

CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT | 1996年 / 803卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb26374.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：32 / 43

页数：12

共 62 条

[1] YEAST MULTIDRUG-RESISTANCE - THE PDR NETWORK [J].

BALZI, E ;

GOFFEAU, A .

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) :71-76

[2]

BALZI E, 1994, J BIOL CHEM, V269, P2206

[3] MULTIPLE OR PLEIOTROPIC DRUG-RESISTANCE IN YEAST [J].

BALZI, E ;

GOFFEAU, A .

BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1073 (02) :241-252

[4]

BARRET JM, 1994, MOL PHARMACOL, V46, P431

[5] ETOPOSIDE (VP-16-213)-INDUCED GENE ALTERATIONS - POTENTIAL CONTRIBUTION TO CELL-DEATH [J].

BERGER, NA ;

CHATTERJEE, S ;

SCHMOTZER, JA ;

HELMS, SR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8740-8743

[6]

BERTRAND R, 1991, CANCER RES, V51, P6280

[7]

BJORNSTI MA, 1989, CANCER RES, V49, P6318

[8] ASSOCIATION OF CROSSOVER POINTS WITH TOPOISOMERASE-I CLEAVAGE SITES - A MODEL FOR NONHOMOLOGOUS RECOMBINATION [J].

BULLOCK, P ;

CHAMPOUX, JJ ;

BOTCHAN, M .

SCIENCE, 1985, 230 (4728) :954-958

[9]

BULLOCK PA, 1985, DIS ABSTR INT SCI B, V46, pB1026

[10]

Chatterjee S, 1989, Cancer Commun, V1, P389

← 1 2 3 4 5 6 7 →